knowledge -WSS

knowledge

author：knowledge 2025-09-28 23:56:36 - browse：8

House Judiciary Chairman Jerrold Nadler (D-NY) listens as Rep. Judy Chu (D-CA) speaks during a news conference. — Reps. Jerry Nadler (D-N.Y.) and Judy Chu (D-Calif.) Joshua Roberts/Getty Images

House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better oversight, citing recent STAT investigations that found insurance companies are using artificial intelligence and algorithmic software to deny care even when people still need it.

On Friday, Rep. Judy Chu of California and Rep. Jerry Nadler of New York spearheaded a letter to the Centers for Medicare and Medicaid Services asking the agency to step up its oversight of Medicare Advantage insurers. Thirty other House Democrats also signed onto the letter.

STAT previously reported Medicare Advantage insurers are using proprietary algorithms and AI to initiate payment denials, but that technology does not fully account for someone’s particular care needs. As a result, many frail patients have been kicked out of nursing homes, faced the prospect of draining their savings, or slogged through a long appeals process to get care they and their clinical teams think they need.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： To avoid data mishandling cases, universities eye AI and other tools

WSS

Alabama frozen embryo ruling has major implications for IVF clinics

How digital tools helped lower hypertension in marginalized patients

Vaccine advisory panel ACIP left half staffed by HHS

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

With competition flaring, obesity drug hits goal in liver disease study

Medical mystery: When a cough is not just a cough

leisure time

knowledge

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Medicare threatens to cut off funding for HCA's Mission hospital

BioMarin wins approval for gene therapy to treat hemophilia A

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Bright Health sells Medicare Advantage business to Molina

The Harvard botanist who searched for psychedelics in the Amazon

Dobbs anniversary: the lost opportunity of abortion as health care

To avoid data mishandling cases, universities eye AI and other tools

Medicare proposal to cover medical devices draws a mixed reaction

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

hotspot

Senators start work on Medicare physician payment reform

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

How digital tools helped lower hypertension in marginalized patients

BioAge raises $170M for combination therapy with Zepbound

What should King Charles tell the public about his cancer?

To avoid data mishandling cases, universities eye AI and other tools

knowledge

leisure time

explore

explore